dihexa potency compared to bdnf synaptogenesis shows neurotrophic activity exceeding in preclinical studies | Alpha BioMed posted on the topic BDNF as a Promising Therapeutic
BDNF as a Promising Therapeutic Agent in Parkinson's Disease Biomedical Reports Characterization of the effects of Semax on Download Scientific Diagram Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted Brain Derived Neurotrophic Factor Differentially Regulates Excitatory and Inhibitory Synaptic Transmission in Hippocampal Cultures Journal of Neuroscience
Pay in 4 interest-free payments of $5.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



